相关实验视频
Updated: Jan 17, 2026

08:36
In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
8.0K
针对卵巢癌中瘤相关巨细胞的治疗方法的进步
Man Li1, Yue Ma1, Tinggeng Dai1
1Department of Gynecological Oncology, The First Hospital of Jilin University, Changchun, China.
Frontiers in immunology
|September 18, 2025
概括
与瘤相关的巨细胞 (TAMs) 通过促进转移和免疫逃避来驱动卵巢癌 (OC) 的进展和治疗耐药性. 了解TAM的起源和可塑性是开发有效的OC疗法的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 妇科瘤学 妇科瘤学
背景情况:
- 卵巢癌 (OC) 是一种致命的妇科恶性瘤.
- 瘤微环境 (TME) 显著影响OC进展和治疗耐药性.
- 瘤相关巨细胞 (TAMs) 是OC TME中的关键免疫细胞,通常采用一种亲瘤M2表型.
研究的目的:
- 审查OC中TAMs的起源,异质性和功能性可塑性.
- 阐明TAMs在OC进展中的机械作用,包括转移,血管新生和免疫逃避.
- 通过外体信号传递和代谢重编程,突出显示TAMs对化学抵抗,特别是抗性的贡献.
主要方法:
- 在卵巢癌中对TAM进行临床前和临床研究的文献综述.
- 对TAM本体发生,表型和功能可塑性的分析.
- 检查TAM介导的OC病原和治疗耐药性的机制.
主要成果:
- TAMs是OC进展的中心调解者,促进表皮细胞-介质细胞过渡 (EMT),血管生成和免疫逃避.
- TAMs通过诸如外体信号传递和代谢重编程等机制,促进治疗耐药性,包括白金耐药性.
- 临床翻译的挑战包括目标毒性和对人类TAM起源的不完全理解.
结论:
- TAMs是卵巢癌病原和治疗耐药性的关键参与者.
- 针对TAM是一个有前途的策略,可以改善OC治疗模式.
- 对TAM起源和可塑性的进一步研究对于有效的临床应用至关重要.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
8.0K
07:59Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
Published on: December 5, 2020
3.0K
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K